Understanding Von Willebrand Disease: Causes, Symptoms, and Daily Management
Von Willebrand disease (VWD) is one of the most common inherited bleeding disorders, yet it often remains undiagnosed for years. The condition occurs due to a deficiency or dysfunction of von Willebrand factor (VWF), a blood protein essential for normal clotting. VWF helps platelets stick to damaged blood vessel walls and also carries clotting factor VIII, another critical component in preventing excessive bleeding.
VWD can affect people of all genders and ages, though symptoms may vary widely. Some individuals experience mild issues and may never realize they have the condition, while others face frequent or severe bleeding episodes that interfere with daily life.
There are three main types of Von Willebrand disease. Type 1 is the most common and involves lower-than-normal levels of VWF. Type 2 occurs when the protein does not function properly, even if levels appear normal. Type 3 is the rarest and most severe form, characterized by very low or nearly absent VWF, leading to serious bleeding complications.
Common symptoms include frequent nosebleeds, easy bruising, prolonged bleeding from cuts, and excessive bleeding after surgery or dental procedures. Women and people who menstruate may experience heavy or prolonged menstrual bleeding, which is often one of the first signs prompting medical evaluation. In severe cases, internal bleeding into joints or muscles may occur, similar to what is seen in hemophilia.
Diagnosing VWD can be challenging because symptoms overlap with other bleeding disorders and laboratory results may fluctuate. Doctors rely on a combination of personal bleeding history, family history, and specialized blood tests that measure VWF levels, activity, and clotting factor VIII.
Although Von Willebrand disease has no cure, it is highly manageable with proper care. Treatment depends on the type and severity of the condition. Some individuals may only need treatment before surgery or after an injury, while others require ongoing therapy. Medications such as desmopressin can stimulate the release of stored VWF, while replacement therapies provide clotting factors directly when needed.